相关实验视频
Updated: Jul 4, 2026

07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
35.0K
射频废除在治疗非转移性髓状甲状腺癌中的有效性:一个案例研究
Hojat Ebrahiminik1, Hossein Chegeni2, Haleh Chehrehgosha3
1Department of Interventional Radiology and Radiation Sciences Research Center, AJA University of Medical Sciences, Tehran, Iran.
Cancer reports (Hoboken, N.J.)
|December 10, 2025
概括
射频除 (RFA) 为甲状腺髓癌 (MTC) 提供了可行的治疗方法,当手术不是一种选择时. 这种微创手术有效地减少了MTC患者的瘤大小和素水平.
科学领域:
- 在瘤学瘤学.
- 干预性放射学 干预性放射学
背景情况:
- 射频除 (RFA) 是一种替代治疗方法,用于那些不适合或拒绝接受手术的患者.
- 关于RFA在治疗甲状腺髓癌 (MTC) 的作用的数据有限.
研究的目的:
- 评估RFA在治疗非转移性髓性甲状腺癌 (MTC) 的疗效.
主要方法:
- 一个83岁的MTC男性的案例研究,他拒绝了甲状腺切除术.
- 进行了射频除 (RFA),随后进行了一年的观察期.
主要成果:
- RFA导致MTC瘤大小显著减少.
- 卡尔西托尼水平在RFA后大幅下降.
- 在随访期间没有观察到任何显著的并发症.
结论:
- 射频切除 (RFA) 证明了甲状腺髓癌 (MTC) 管理的可接受结果.
- 需要进一步的研究来确认长期疗效,并将RFA与MTC的传统治疗方法进行比较.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

